BRIEF published on 10/17/2024 at 17:50, 1 month 3 days ago Virbac: Positive financial results at the end of September Strategic Acquisitions Financial Growth VIRBAC 2024 Results Animal Market
BRIEF published on 10/03/2024 at 12:07, 1 month 18 days ago Virbac: Declaration on Shares and Voting Rights Euronext Paris Voting Rights Actions Financial Transparency VIRBAC
PRESS RELEASE published on 10/03/2024 at 12:02, 1 month 18 days ago Virbac : Declaration of the number of shares and voting rights 09/2024 Declaration of the number of shares and voting rights for VIRBAC on Euronext Paris, with total voting rights of 12,708,271 and total shares representing the share capital of 8,390,660 as of September 30, 2024 Euronext Paris Voting Rights Shares Financial Market VIRBAC
BRIEF published on 09/16/2024 at 14:05, 2 months 4 days ago Virbac corrects the amount of its share capital Share Capital Press Release Animal Health Correction VIRBAC
BRIEF published on 09/13/2024 at 17:50, 2 months 7 days ago Virbac announces the conditions of Sébastien Huron's departure Resignation Remuneration VIRBAC Sebastian Huron Non-competition Clause
PRESS RELEASE published on 09/13/2024 at 17:45, 2 months 7 days ago Virbac: Information on the departure of Sébastien Huron Virbac's board of directors sets out terms of Sébastien Huron's departure as CEO. Financial terms of departure include fixed and variable compensation for 2024 Compensation CEO Departure VIRBAC Financial Terms Sébastien Huron
PRESS RELEASE published on 09/13/2024 at 17:45, 2 months 7 days ago Virbac : the board of directors announces a capital reduction through cancellation of treasury shares Virbac's board of directors announces a capital reduction by canceling 67,340 treasury shares. Dick family group now holds 50.09% of share capital and 66.20% of voting rights Treasury Shares Shareholder Structure Capital Reduction VIRBAC Dick Family Group
PRESS RELEASE published on 09/10/2024 at 15:24, 2 months 10 days ago Virbac : Declaration of the number of shares and voting rights 08/2024 Announcement of total shares and voting rights on Euronext Paris with ISIN code FR0000031577 for Virbac. Net total voting rights: 12,693,388 Euronext Paris Voting Rights Shares ISIN Code VIRBAC
BRIEF published on 09/10/2024 at 15:22, 2 months 10 days ago Virbac: Declaration of Shares and Voting Rights Voting Rights Shares Euronext Financial Disclosure VIRBAC
PRESS RELEASE published on 09/10/2024 at 15:17, 2 months 10 days ago Virbac : Declaration of the number of shares and voting rights 07/2024 Declaration of the number of shares and voting rights for VIRBAC on Euronext Paris. Total voting rights: 12,776,794. Net voting rights: 12,693,388 Euronext Paris Voting Rights Shares Financial Market VIRBAC
Published on 11/21/2024 at 13:00, 31 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 31 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 31 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 31 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 31 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 56 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 16 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 33 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 11 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 46 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 46 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
